Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation

Abstract

Edited by Jesus AvilaKeywords: Transthyretin Amyloid inhibitor Fibril formation (À)-Epigallocatechin-3-gallate Curcumin a b s t r a c t Several natural polyphenols with potent inhibitory effects on amyloid fibril formation have been reported. Herein, we studied modulation of transthyretin (TTR) fibrillogenesis by selected polyphenols. We demonstrate that both curcumin and nordihydroguaiaretic acid (NDGA) bind to TTR and stabilize the TTR tetramer. However, while NDGA slightly reduced TTR aggregation, curcumin strongly suppressed TTR amyloid fibril formation by generating small ''off-pathway'' oligomers and EGCG maintained most of the protein in a non-aggregated soluble form. This indicates alternative mechanisms of action supported by the occurrence of different non-toxic intermediates. Moreover, EGCG and curcumin efficiently disaggregated pre-formed TTR amyloid fibrils. Our studies, together with the safe toxicological profile of these phytochemicals may guide a novel pharmacotherapy for TTR-related amyloidosis targeting different steps in fibrillogenesis. Structured summary of protein interactions:TTR binds to TTR by comigration in gel electrophoresis (View interaction) TTR binds to TTR by dynamic light scattering (View interaction) TTR binds to TTR by electron microscopy (View interaction)

A Caenorhabditis elegans–based assay recognizes immunoglobulin light chains causing heart amyloidosis

“…These drugs were reported to influence the toxic properties of several amyloidogenic proteins. 31,[42][43][44][45][46][47] TETRA, besides its ability to disrupt and/or inhibit amyloid fibril formation, also hinders the oxidative stress by inhibiting ROS generation and stimulating endogenous antioxidant enzymes, such as superoxide dismutase and glutathione peroxidase. 31 Preliminary data indicate that EGCG can produce clinical benefits with possible reduction of the cardiac amyloid deposits in patients with AL amyloidosis.…”

How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicity in Vitro

“…1A) are also found in numerous other fibril inhibitors (14, 15, 18 -20). EGCG is not specific toward ␣SN and has been shown to inhibit the fibrillation of numerous proteins (21)(22)(23)(24)(25)(26)(27). At equimolar concentrations, EGCG preferentially binds the C terminus of ␣SN (Asp-119, Ser-129, Glu-130, and Asp-135) (13).…”

Natural Compounds May Open New Routes to Treatment of Amyloid Diseases

“…The general mechanism of EGCG has now been confirmed in various misfolded protein systems [81,95,96] and the yeast prion Sup35 [86]. However, mechanistic details seem to depend on the stability of the protein aggregates that are formed with the aid of EGCG.…”

“…After treatment with EGCG, the yeast prion Sup35 loses its ability to replicate the fibrillar structure [86]. EGCG degrades fibrils of transthyretin [96]; fibrils of merozoite surface protein 2 are also transformed into an amorphous structure by EGCG [103]. We were able to elucidate the mechanism by which EGCG acts on αS and Aβ fibrils [104].…”